Myriad Genetics brings you a casual, yet educational podcast about modern topics in Urology. Because every man with prostate cancer deserves a better answer.
Dr. Mike Gambla from Central Ohio Urology Group joins The Modern Urologist to talk about his experience with private equity acquisitions (PE) in the Urology space. The idea of potential culture disruptions and other pros and cons of PE acquisitions are discussed at length. Dr. Gambla offers his own insights to any independent practice considering an acquisition. The conversation changes to the role nurse navigators play in getting patients with advanced disease states better care through second and third line therapies. The need for analytics to improve patient outcomes and forecast practice needs are also discussed.
Is your practice considering an acquisition? Listen along as Dr. Mike Gambla from Central Ohio Urology Group shares his experience with private equity acquisitions in the Urology space. Mike also talks about the potential gains and possible cultural disruptions that can arise with a private equity acquisition.
The conversation changes to the role nurse navigators play in getting patients with advanced disease states better care through second and third line therapies, the role analytics can play in improving patient outcomes and forecast practice needs are also discussed.
